FDA panel endorses Pfizer shots for 5- to 11-year-olds: Experts say it is ‘unnecessary, premature and will do more harm than good’
The U.S. Food and Drug Administration’s advisory panel today voted to recommend the agency allow Pfizer to amend its Emergency Use Authorization for its COVID vaccine for children 5 through 11 years old, despite a host of objections from scientists and physicians.
News
•
